Journal of
Medicinal Plants Research

  • Abbreviation: J. Med. Plants Res.
  • Language: English
  • ISSN: 1996-0875
  • DOI: 10.5897/JMPR
  • Start Year: 2007
  • Published Articles: 3834

Full Length Research Paper

Protective potential of Avena sativa seed mucilaginous extract against hyperlipidemia indicated by improved biomarkers and histopathology

Ibtsam M. Gheith
  • Ibtsam M. Gheith
  • Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Taibah University, 344 Medinah, Saudi Arabia.
  • Google Scholar
Abubakr M. El-Mahmoudy
  • Abubakr M. El-Mahmoudy
  • Department of Pharmacology, Faculty of Veterinary, Medicine, Benha University 13736 Moshtohor, Egypt.
  • Google Scholar

  •  Received: 14 November 2018
  •  Accepted: 21 December 2018
  •  Published: 10 January 2019


Hyperlipidemia is one of the major health concerns worldwide. The present study aimed at utilizing clinicopathological tools to investigate the possible improving effect of Avena sativa mucilaginous extract (ASE) on lipid metabolic and liver function profiles in albino rats. The rats were rendered hyperlipidemic by 6-week supplementation of high-fat diet ad libitum. The rats were grouped into seven groups; with different treatment applications. Rats of group-I received normal diet and served as normal control; those of group-II were kept on high-fat (cholesterol 1% + coconut oil 2%) diet for 6 weeks and served as diseased control. Rats in group-III were kept on high-fat diet and received ezetimibe (1 mg/Kg B. Wt, orally, daily) and served as standard. Those in group-IV and V were kept on high-fat diet and received ASE at doses of 25 and 50 mg/Kg B. Wt., orally, daily (small and high doses, SD and HD, respectively) and served as treated-SD and treated-HD, respectively. While the last two groups (VI and VII) were kept on normal diet and received SD and HD of ASE. Blood samples for serum were taken for clinicochemical analysis on days 28 (4 weeks) and 42 (6 weeks) of the experiment and tissue specimens were taken for histopathology. ASE significantly (P<0.05) decreased the elevated serum lipid profile parameters, including total lipids, tri-acylglycerols (TAGs), cholesterol, LDL-C, VLDL-C, but significantly (P<0.05) normalized the serum HDL-C concentrations of rats kept on high-fat diet. Administration of A. sativa extract significantly decreased elevated serum liver enzyme activities in samples taken from animals kept on high-fat diet compared to the diseased untreated ones. Observations from histopathological examination were parallel and explanatory to clinicochemical analytical results. These data may suggest that the aqueous mucilaginous extract of A. sativa seed has a good health impact in cases associated with hyperlipidemia indicated by clinical pathology.

Key words: Avena sativa, antihyperlipidemic, clinical pathology, liver function, phytotherapy, phytomedicine.